Cargando…
Differential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in Germany
BACKGROUND: The World Health Organization recommends early antiviral treatment for patients with severe influenza illness or those at increased risk for severe illness. OBJECTIVES: The aim of this study was to determine the proportion of cases with laboratory‐confirmed A(H1N1)pdm09 infection that ha...
Autores principales: | Reuss, Annicka, Dehnert, Manuel, Buda, Silke, Haas, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634277/ https://www.ncbi.nlm.nih.gov/pubmed/23957666 http://dx.doi.org/10.1111/irv.12152 |
Ejemplares similares
-
Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore
por: Chen, Mark I. C., et al.
Publicado: (2013) -
Counting pandemic deaths: comparing reported numbers of deaths from influenza A(H1N1)pdm09 with estimated excess mortality
por: Gran, Jon Michael, et al.
Publicado: (2013) -
A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection
por: Ruggiero, Tina, et al.
Publicado: (2013) -
Characterization of neuraminidase inhibitor‐resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post‐pandemic periods in Japan
por: Takashita, Emi, et al.
Publicado: (2013) -
Unchanged Severity of Influenza A(H1N1)pdm09 Infection in Children during First Postpandemic Season
por: Altmann, Mathias, et al.
Publicado: (2012)